Novo Nordisk to spend $4.1B to build new plant for obesity drugs in N.C.
2024-06-24
Victor Golmer/iStock Editorial via Getty Images Novo Nordisk (NVO) will invest $4.1B to build a second fill and finish manufacturing facility in Clayton, N.C. focused on injectables medications, including current and future ones for obesity. The development comes as Novo, which makes the weight loss drug Wegovy (semaglutide), and rivalContinue Reading